NM_014760.4:c.100C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014760.4(TATDN2):c.100C>T(p.Pro34Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000996 in 1,605,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014760.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TATDN2 | NM_014760.4 | c.100C>T | p.Pro34Ser | missense_variant | Exon 2 of 8 | ENST00000448281.7 | NP_055575.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TATDN2 | ENST00000448281.7 | c.100C>T | p.Pro34Ser | missense_variant | Exon 2 of 8 | 1 | NM_014760.4 | ENSP00000408736.2 | ||
ENSG00000289763 | ENST00000699225.1 | c.132C>T | p.Pro44Pro | synonymous_variant | Exon 2 of 2 | ENSP00000514219.1 | ||||
ENSG00000272410 | ENST00000437082.5 | n.-72C>T | upstream_gene_variant | 2 | ENSP00000402783.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000568 AC: 14AN: 246326Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133592
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1453594Hom.: 0 Cov.: 31 AF XY: 0.00000416 AC XY: 3AN XY: 721946
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.100C>T (p.P34S) alteration is located in exon 2 (coding exon 1) of the TATDN2 gene. This alteration results from a C to T substitution at nucleotide position 100, causing the proline (P) at amino acid position 34 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at